Latest Opdivo news
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
posted September 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
AAAAI: No Increase Seen in Asthma Exacerbations With ICI Use for Melanoma, Renal Cell Carcinoma
posted March 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Gene Mutation Identified That Increases Lung Cancer Risk 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer 
Entinostat + Nivolumab Yields Durable Results in Some Pancreatic Cancer Patients 
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma 
Adjuvant Nivolumab Slows Muscle-Invasive Urothelial Carcinoma Monthly Specialist Briefings
Stay Connected
